Latest News
- Annual Report for the Year Ended December 31, 2018 June 28, 2019
- Verseon showcases DME program at BIO 2019 June 4, 2019
- Verseon presents DME candidate at ARVO 2019 April 30, 2019
By combining proprietary advancements in modeling the physics of molecular interactions and sophisticated optimization algorithms, Verseon is poised to change the pharmaceutical industry
Proprietary Platform
Consistently designs novel drug candidates that are unlikely to be found using conventional methods
Drug Programs
Multiple therapeutic areas, all with unmet (or poorly met) medical needs